A detailed history of State Street Corp transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, State Street Corp holds 169,690 shares of HOOK stock, worth $719,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169,690
Previous 160,190 5.93%
Holding current value
$719,485
Previous $113,000 11.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.59 - $1.04 $5,605 - $9,880
9,500 Added 5.93%
169,690 $100,000
Q3 2023

Nov 14, 2023

SELL
$0.58 - $0.91 $5,210 - $8,175
-8,984 Reduced 5.31%
160,190 $99,000
Q2 2023

Aug 14, 2023

BUY
$0.71 - $1.97 $18,720 - $51,942
26,367 Added 18.46%
169,174 $148,000
Q4 2022

Feb 14, 2023

SELL
$0.73 - $14.6 $23,274 - $465,491
-31,883 Reduced 18.25%
142,807 $115,000
Q3 2022

Nov 15, 2022

BUY
$1.27 - $15.0 $717 - $8,475
565 Added 0.32%
174,690 $234,000
Q2 2022

Aug 15, 2022

SELL
$1.33 - $2.31 $338,363 - $587,684
-254,409 Reduced 59.37%
174,125 $284,000
Q1 2022

May 16, 2022

BUY
$1.26 - $2.52 $122,291 - $244,583
97,057 Added 29.28%
428,534 $977,000
Q4 2021

Feb 14, 2022

SELL
$2.33 - $5.94 $68,255 - $174,006
-29,294 Reduced 8.12%
331,477 $772,000
Q3 2021

Nov 15, 2021

BUY
$5.89 - $9.35 $204,730 - $324,996
34,759 Added 10.66%
360,771 $2.13 Million
Q2 2021

Aug 16, 2021

BUY
$9.16 - $19.51 $1.18 Million - $2.52 Million
129,214 Added 65.66%
326,012 $2.99 Million
Q1 2021

May 17, 2021

SELL
$10.64 - $14.7 $32,228 - $44,526
-3,029 Reduced 1.52%
196,798 $2.65 Million
Q4 2020

Feb 16, 2021

SELL
$9.32 - $13.63 $9,133 - $13,357
-980 Reduced 0.49%
199,827 $2.22 Million
Q3 2020

Nov 10, 2020

BUY
$8.59 - $11.89 $69,450 - $96,130
8,085 Added 4.2%
200,807 $1.9 Million
Q2 2020

Aug 14, 2020

BUY
$7.23 - $12.1 $540,160 - $904,003
74,711 Added 63.31%
192,722 $2.24 Million
Q1 2020

May 11, 2020

BUY
$5.9 - $13.8 $696,264 - $1.63 Million
118,011 New
118,011 $974,000

Others Institutions Holding HOOK

About HOOKIPA Pharma Inc.


  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $219M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.